These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology. Thrash-Bingham CA; Salazar H; Freed JJ; Greenberg RE; Tartof KD Cancer Res; 1995 Dec; 55(24):6189-95. PubMed ID: 8521412 [TBL] [Abstract][Full Text] [Related]
4. Chromosome 3p deletion in a renal cell carcinoma cell line established from a patient with von Hippel-Lindau disease. Kohno T; Sekine T; Tobisu K; Oshimura M; Yokota J Jpn J Clin Oncol; 1993 Aug; 23(4):226-31. PubMed ID: 8105119 [TBL] [Abstract][Full Text] [Related]
5. Genomic organization and chromosomal localization of the human CUL2 gene and the role of von Hippel-Lindau tumor suppressor-binding protein (CUL2 and VBP1) mutation and loss in renal-cell carcinoma development. Clifford SC; Walsh S; Hewson K; Green EK; Brinke A; Green PM; Gianelli F; Eng C; Maher ER Genes Chromosomes Cancer; 1999 Sep; 26(1):20-8. PubMed ID: 10441001 [TBL] [Abstract][Full Text] [Related]
6. Solid renal tumor severity in von Hippel Lindau disease is related to germline deletion length and location. Maranchie JK; Afonso A; Albert PS; Kalyandrug S; Phillips JL; Zhou S; Peterson J; Ghadimi BM; Hurley K; Riss J; Vasselli JR; Ried T; Zbar B; Choyke P; Walther MM; Klausner RD; Linehan WM Hum Mutat; 2004 Jan; 23(1):40-6. PubMed ID: 14695531 [TBL] [Abstract][Full Text] [Related]
7. Detection of von Hippel-Lindau disease gene mutations in paraffin-embedded sporadic renal cell carcinoma specimens. Zhuang Z; Gnarra JR; Dudley CF; Zbar B; Linehan WM; Lubensky IA Mod Pathol; 1996 Aug; 9(8):838-42. PubMed ID: 8871925 [TBL] [Abstract][Full Text] [Related]
9. [Analysis of kidney tumors in trichloroethylene exposed workers by comparative genomic hybridization and DNA sequence analysis]. Schraml P; Zhaou M; Richter J; Brüning T; Pommer M; Sauter G; Mihatsch MJ; Moch H Verh Dtsch Ges Pathol; 1999; 83():218-24. PubMed ID: 10714214 [TBL] [Abstract][Full Text] [Related]
10. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis. Clifford SC; Prowse AH; Affara NA; Buys CH; Maher ER Genes Chromosomes Cancer; 1998 Jul; 22(3):200-9. PubMed ID: 9624531 [TBL] [Abstract][Full Text] [Related]
11. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC). Singh RB; Amare Kadam PS Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529 [TBL] [Abstract][Full Text] [Related]
12. A combination of molecular cytogenetic analyses reveals complex genetic alterations in conventional renal cell carcinoma. Strefford JC; Stasevich I; Lane TM; Lu YJ; Oliver T; Young BD Cancer Genet Cytogenet; 2005 May; 159(1):1-9. PubMed ID: 15860350 [TBL] [Abstract][Full Text] [Related]
13. Clear cell tubulopapillary renal cell carcinoma: a study of 36 distinctive low-grade epithelial tumors of the kidney. Aydin H; Chen L; Cheng L; Vaziri S; He H; Ganapathi R; Delahunt B; Magi-Galluzzi C; Zhou M Am J Surg Pathol; 2010 Nov; 34(11):1608-21. PubMed ID: 20924276 [TBL] [Abstract][Full Text] [Related]
14. About the origin and development of hereditary conventional renal cell carcinoma in a four-generation t(3;8)(p14.1;q24.23) family. Valle L; Cascón A; Melchor L; Otero I; Rodríguez-Perales S; Sánchez L; Cruz Cigudosa J; Robledo M; Weber B; Urioste M; Benítez J Eur J Hum Genet; 2005 May; 13(5):570-8. PubMed ID: 15756303 [TBL] [Abstract][Full Text] [Related]
15. Multifocal bilateral renal cell carcinoma and retinal angiomas in a patient with de novo von Hippel-Lindau disease: identification of a new germline mutation. Sessa A; Battini G; Meroni M; Pitingolo F; Righetti M; Ciotti P; Di Maria E; Bellone E; Ajmar F; Mandich P J Nephrol; 2005; 18(2):209-12. PubMed ID: 15931650 [TBL] [Abstract][Full Text] [Related]
16. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas. Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792 [TBL] [Abstract][Full Text] [Related]
17. Molecular study of a new family with hereditary renal cell carcinoma and a translocation t(3;8)(p13;q24.1). Meléndez B; Rodríguez-Perales S; Martínez-Delgado B; Otero I; Robledo M; Martínez-Ramírez A; Ruiz-Llorente S; Urioste M; Cigudosa JC; Benítez J Hum Genet; 2003 Feb; 112(2):178-85. PubMed ID: 12522559 [TBL] [Abstract][Full Text] [Related]
18. Genetics of renal-cell carcinoma and evidence for a critical role for von Hippel-Lindau in renal tumorigenesis. Gnarra JR; Lerman MI; Zbar B; Linehan WM Semin Oncol; 1995 Feb; 22(1):3-8. PubMed ID: 7855617 [TBL] [Abstract][Full Text] [Related]
19. Precancerous lesions in the kidney. Van Poppel H; Nilsson S; Algaba F; Bergerheim U; Dal Cin P; Fleming S; Hellsten S; Kirkali Z; Klotz L; Lindblad P; Ljungberg B; Mulders P; Roskams T; Ross RK; Walker C; Wersäll P Scand J Urol Nephrol Suppl; 2000; (205):136-65. PubMed ID: 11144893 [TBL] [Abstract][Full Text] [Related]
20. Characterization of quantitative chromosomal abnormalities in renal cell carcinomas by interphase four-color fluorescence in situ hybridization. Receveur AO; Couturier J; Molinié V; Vieillefond A; Desangles F; Guillaud-Bataille M; Danglot G; Coullin P; Bernheim A Cancer Genet Cytogenet; 2005 Apr; 158(2):110-8. PubMed ID: 15796957 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]